“…The commercial antibodies against the following proteins were used: Na/KATPase (monoclonal anti-peptide antibody against the α1 subunit of the human protein, Santa Cruz Biotechnology, CA, USA), metallothionein (monoclonal antibody against the polymerized MT1 and MT2 horse holoproteins; Dako North America, CA, USA), actin (monoclonal anti-peptide antibody; Millipore, MA, USA), and α-tubulin (monoclonal antibody against the see urchin filament; Sigma, MO, USA). The non-commercial antibodies against the following proteins were used: megalin (polyclonal antibody against the rat holoprotein; characterized in Abbate et al, 1994 andSabolić et al, 2002), CAM105 (polyclonal antibody against the rat holoprotein; characterized in Sabolić et al, 1992a), AQP1; polyclonal antibody against the rat holoprotein; characterized in Sabolić et al, 1992b), and V-ATPase (polyclonal anti-peptide antibody against the 31 kDa ("E") subunit;…”